TORNTPHARM.NS Cash Flow
Torrent Pharmaceuticals Ltd.
Profit & Loss Balance Sheet Cash Flow
Cash Flow · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-24 00:34
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Net Cash from Operating Activities | ₹23.68 Bn | ₹32.66 Bn | ₹25.85 Bn | ₹30.23 Bn | CashFlowsFromUsedInOperatingActivities |
| Net Cash from Investing Activities | ₹-23.56 Bn | ₹-1.68 Bn | ₹-5.40 Bn | ₹-127.13 Bn | CashFlowsFromUsedInInvestingActivities |
| Net Cash from Financing Activities | ₹0.77 Bn | ₹-27.79 Bn | ₹-22.98 Bn | ₹101.51 Bn | CashFlowsFromUsedInFinancingActivities |
| Effect of Exchange Rate Changes | ₹0.21 Bn | ₹0.08 Bn | ₹-0.09 Bn | ₹0.83 Bn | EffectOfExchangeRateChangesOnCashAndCashEquivalents |
| Net Increase/(Decrease) in Cash | ₹1.10 Bn | ₹3.27 Bn | ₹-2.62 Bn | ₹5.44 Bn | IncreaseDecreaseInCashAndCashEquivalents |
| Cash and Cash Equivalents (Closing) | ₹3.98 Bn | ₹5.08 Bn | N/A | N/A | CashAndCashEquivalentsCashFlowStatement |
Every figure above is the exact value of the named XBRL element from TORNTPHARM.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).